Bottom line
HRISX vs IEFA: the short answer
HRISX (Harbor International Small Cap Fund) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds.
But IEFA is far broader, holding 2,632 positions to 65 for HRISX, so beyond the top names it adds exposure HRISX doesn't have.
IEFA is cheaper at 0.07% vs 1.15% — a difference of $108 a year per $10,000 invested.
Over five years, HRISX returned +7.5% a year vs +4.5% for IEFA (reporting dates differ).
Updated Nov 19, 2026
HRISX vs IEFA side by side
| HRISX | IEFA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Oakmark (Harris) | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 1.15% | 0.07% |
| Annual cost per $10k | $115 | $7 |
| 10-yr cost on $10k (prospectus) | $1,575 | $90 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +24.5% | +3.4% |
| 5-yr return (annualized) | +7.5% | +4.5% |
| 10-yr return (annualized) | +8.2% | +5.4% |
| Best quarter | — | +18.0% |
| Worst quarter | — | −23.5% |
| Net assets (fund) | $196.8M | $190.1B |
| Number of holdings | 65 | 2,632 |
| Portfolio turnover | 36% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
HRISX and IEFA share none of their top holdings.
HRISX top 10
- Nakanishi Inc — 1.94%
- Clarkson PLC — 1.90%
- Hoshizaki Corp — 1.89%
- Glanbia PLC — 1.89%
- Rs Group Plc — 1.88%
- Computer Engineering & Consulting Ltd — 1.86%
- JCDecaux SE — 1.85%
- Kansai Paint Co Ltd — 1.84%
- Zigup PLC — 1.83%
- TP ICAP Group PLC — 1.82%
IEFA top 10
- ASML Holding N.V. — 2.50%
- Hsbc Holdings Plc — 1.42%
- Roche Holding AG — 1.20%
- Novartis AG — 1.12%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
- Nestle S.A. — 1.00%
- Astrazeneca Plc — 1.00%
- Shell Plc — 1.00%
- Siemens Aktiengesellschaft — 0.95%
- Mitsubishi UFJ Financial Group, Inc. — 0.93%
FAQ
What is the difference between HRISX and IEFA?
Which is cheaper, HRISX or IEFA?
Should I own both HRISX and IEFA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.